Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Peptides. 2010 Aug 17;31(11):2075–2082. doi: 10.1016/j.peptides.2010.07.023

Table 2.

Maximal active stress response (mN/mm2) following 30 μM phenylephrine, 0.01 μM urotensin II, and 109 mM K+PSS. Control – Vehicle animals (n=9), UTII − 4 week administration of urotensin II (n=6); VO − 4 week volume overload (n=5); VO+UTII − 4 week VO + 4 week UTII administration (n = 4). Data are reported as mean ± sem

Groups PE (30 μM) UTII (0.01 μM) 109 mM K+PSS
Control 4.15 ± 0.42 1.88 ± 0.31 4.57 ± 0.37
UTII 2.25 ± 0.43* 0.65 ± 0.13* 4.27 ± 0.43
VO 2.86 ± 0.29* 1.70 ± 0.13 1.99 ± 0.36*
VO+UTII 2.23 ± 0.25* 1.37 ± 0.15 3.73 ± 1.12
*

p<0.05 vs. Control